1. Binding Antibodies Responses to SARS-COV-2 Infection in Hospitalized Patients and Vaccinated Subjects: A Longitudinal Prospective Observational Study.
- Author
-
Alshahrani, Mohammed Saeed, Aldahhan, Razan, Macadato, Nabela Calamata, Alkhalifah, Zahra, Tahan, Mohamed R. El, Alnimr, Amani, Alnabi, Mohammed Alabdrab, Almishkab, Fatima, Almusairii, Jawaher, Asonto, Laila Perlas, Almusawi, Sajjad Mohammed, Almussalam, Mohammed, Alsanea, Rawan, Albakheet, Mubarak Khalifa, Albrahim, Talal Ali, Alammar, Moaz Saad, Albehair, Maan, Alkhater, Suzan A., Alsulaibikh, Amal, and Aljumaan, Mohammed
- Subjects
SARS-CoV-2 ,COVID-19 ,NATURAL immunity ,ANTIBODY formation ,ANTIBODY titer - Abstract
Background: Prevalence of seropositivity following SARS-CoV-2 infection is vital in evaluating herd immunity. However, depending on illness severity, it remains unclear whether the breadth and magnitude of immune response to SARS-CoV-2 infection is for short or long term. Objective: To test the persistence of humoral antibody responses after SARS-CoV-2 exposure in patients with different illness severity and among volunteers who had been vaccinated. Methods: This study was conducted in two Saudi Arabian tertiary hospitals. Participants were categorized as critically ill COVID-19 patients, non-critically ill COVID-19 patients, or vaccinated volunteers. We collected demographic data, COVID-19 exposure history, symptoms, vaccination details, and serum samples to analyze antibody persistence. We evaluated SARS-CoV-2 antibody concentrations in COVID-19 patients with varying disease severity and age groups, as well as in BNT162b2-vaccinated individuals, focusing on IgG levels against the S.FL and S1 domains of the spike protein. Results: The study included 172 adults: 92 unvaccinated hospitalized COVID-19 patients and 80 vaccinated volunteers. All vaccinated subjects demonstrated seropositivity to the SARS-CoV-2 spike protein, with nearly 80% having a median antibody titer of 13,500 AU/mL. Notably, vaccinated subjects exhibited significantly higher IgG levels than naturally infected patients (P < 0.001), including higher S.FL and S1 titers, regardless of severity. Age, comorbidities, and previous infections influenced S-specific antibody levels. Among hospitalized patients, 58% required intensive care, with 28- and 90-day mortality rates of 23% and 43%, respectively. Conclusion: These findings shed light on the immune response dynamics following SARS-CoV-2 infection compared to vaccinated individuals, where the latter showed significantly higher level of antibodies response, providing crucial insights for evaluating short-term herd immunity and the effectiveness of natural infection-induced immunity. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF